Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers

Nolasiban is an orally active oxytocin receptor antagonist being developed to increase the efficiency of assisted reproductive technologies. This study evaluated the pharmacokinetics, pharmacodynamics, and cardiac safety of nolasiban in 45 healthy women of child-bearing age. Nolasiban was administer...

Full description

Saved in:
Bibliographic Details
Published in:Sci Rep
Main Authors: Täubel, Jörg, Lorch, Ulrike, Spencer, Christopher S., Freier, Anne, Camilleri, Dorothée, Djumanov, Dilshat, Ferber, Georg, Marchand, Line, Gotteland, Jean-Pierre, Pohl, Oliver
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7973531/
https://ncbi.nlm.nih.gov/pubmed/33739022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-85650-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items